The dimer interface of ERK1/2 provides a potential strategy for selective inhibition of pathological cardiac hypertrophy

被引：0
|
作者：
Tomasovic, A. [1 ]
Kramer, S. [1 ]
Huemmert, M. [1 ]
Katus, Ha [2 ]
Mueller, O. [2 ]
Lorenz, K. [3 ]
机构：
[1] Univ Wurzburg, Inst Pharmacol & Toxicol, Wurzburg, Germany
[2] Univ Hosp Heidelberg, Internal Med 3, Heidelberg, Germany
[3] Leibniz Inst Analyt Sci ISAS, Dortmund, Germany
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2017年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
810
引用
收藏
页码：187 / 187
页数：1
相关论文
共 50 条
  • [1] A new potential strategy for targeting pathological cardiac hypertrophy: the dimer interface of ERK1/2
    Tomasovic, A.
    Huemmert, M.
    Lorenz, K. Kristina
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 432 - 432
  • [2] The dimer interface of ERK1/2 provides an alternative targeting strategy to interfere with ERK1/2 mediated cardiac hypertrophy
    Tomasovic, A.
    Huemmert, M.
    Kramer, S.
    Gruse, T.
    Katus, H. A.
    Lohse, M. J.
    Mueller, O.
    Lorenz, K.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2016, 389 (01) : S4 - S5
  • [3] Selective interference with nuclear ERK1/2 signaling prevents pathological cardiac hypertrophy
    Ruppert, C.
    Vidal, M.
    Lohse, M. J.
    Lorenz, K.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 : S68 - S68
  • [4] Monomeric ERK2 attenuates ERK1/2-mediated pathological cardiac hypertrophy
    Tomasovic, Angela
    Huemmert, Martin
    Ruppert, Catharina
    Lohse, Martin J.
    Lorenz, Kristina
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2014, 387 : S20 - S20
  • [5] Inhibition of ERK dimerization prevents the development of ERK1/2-mediated cardiac hypertrophy
    Huemmert, M.
    Vidal, M.
    Schmitt, J. P.
    Lohse, M. J.
    Lorenz, K.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2011, 383 : 26 - 26
  • [6] SPECIFIC INTERFERENCE WITH NUCLEAR ERK1/2 SIGNALING PREVENTS PATHOLOGICAL CARDIAC HYPERTROPHY
    Ruppert, C.
    Deiss, K.
    Herrmann, S.
    Vidal, M.
    Oezkur, M.
    Gorski, A.
    Weidemann, F.
    Lohse, M. J.
    Lorenz, K.
    CARDIOLOGY, 2013, 126 : 17 - 17
  • [7] Characterization of a peptide that interferes with ERK1/2-mediated pathological cardiac hypertrophy
    Tomasovic, A.
    Huemmert, M.
    Ruppert, C.
    Lorenz, K.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2015, 388 : S41 - S41
  • [8] CREG, a new regulator of ERK1/2 in cardiac hypertrophy
    Xu, L
    Liu, JM
    Chen, LY
    JOURNAL OF HYPERTENSION, 2004, 22 (08) : 1579 - 1587
  • [9] A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy
    Kristina Lorenz
    Joachim P Schmitt
    Eva M Schmitteckert
    Martin J Lohse
    Nature Medicine, 2009, 15 : 75 - 83
  • [10] A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy
    Lorenz, Kristina
    Schmitt, Joachim P.
    Schmitteckert, Eva M.
    Lohse, Martin J.
    NATURE MEDICINE, 2009, 15 (01) : 75 - 83
12345